Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.6M Buy
262,901
+50,970
+24% +$5.88M 0.13% 103
2025
Q4
$22.3M Buy
211,931
+88,256
+71% +$8.28M 0.09% 132
2025
Q3
$10.4M Buy
123,675
+3,804
+3% +$313K 0.05% 205
2025
Q2
$9.49M Buy
119,871
+15,679
+15% +$1.25M 0.05% 211
2025
Q1
$8.32M Buy
104,192
+12,942
+14% +$1.21M 0.05% 199
2024
Q4
$8.73M Buy
91,250
+22,006
+32% +$2.27M 0.05% 189
2024
Q3
$7.86M Buy
69,244
+5,424
+8% +$644K 0.05% 165
2024
Q2
$8.03M Buy
63,820
+13,232
+26% +$1.7M 0.05% 157
2024
Q1
$6.68M Buy
50,588
+3,704
+8% +$457K 0.05% 157
2023
Q4
$5.11M Buy
46,884
+3,173
+7% +$329K 0.04% 184
2023
Q3
$4.5M Buy
43,711
+2,351
+6% +$253K 0.04% 177
2023
Q2
$4.77M Sell
41,360
-55
-0.1% -$6.25K 0.04% 173
2023
Q1
$4.41M Buy
41,415
+4,336
+12% +$468K 0.04% 169
2022
Q4
$4.11M Sell
37,079
-1,172
-3% -$120K 0.05% 167
2022
Q3
$3.29M Buy
38,251
+3,311
+9% +$296K 0.04% 177
2022
Q2
$3.19M Buy
34,940
+4,433
+15% +$393K 0.04% 173
2022
Q1
$2.5M Buy
30,507
+5,080
+20% +$401K 0.03% 196
2021
Q4
$1.95M Buy
25,427
+185
+0.7% +$14.7K 0.03% 205
2021
Q3
$1.9M Buy
25,242
+2,159
+9% +$164K 0.03% 173
2021
Q2
$1.79M Sell
23,083
-42
-0.2% -$3.12K 0.03% 139
2021
Q1
$1.7M Buy
23,125
+2,424
+12% +$179K 0.03% 125
2020
Q4
$1.62M Buy
20,701
+1,367
+7% +$105K 0.04% 90
2020
Q3
$1.53M Sell
19,334
-225
-1% -$17.6K 0.05% 74
2020
Q2
$1.44M Buy
19,559
+2,274
+13% +$171K 0.04% 73
2020
Q1
$1.27M Buy
17,285
+1,507
+10% +$118K 0.04% 93
2019
Q4
$1.37M Buy
15,778
+9,199
+140% +$756K 0.05% 62
2019
Q3
$528K Buy
6,579
+124
+2% +$9.94K 0.02% 90
2019
Q2
$516K Sell
6,455
-2,734
-30% -$209K 0.02% 92
2019
Q1
$729K Sell
9,189
-794
-8% -$59.4K 0.03% 76
2018
Q4
$728K Buy
9,983
+2,409
+32% +$170K 0.04% 69
2018
Q3
$513K Sell
7,574
-125
-2% -$7.96K 0.02% 91
2018
Q2
$446K Sell
7,699
-137
-2% -$7.73K 0.02% 97
2018
Q1
$407K Sell
7,836
-6
-0.1% -$324 0.03% 77
2017
Q4
$421K Sell
7,842
-57
-0.7% -$3.16K 0.03% 69
2017
Q3
$483K Sell
7,899
-131
-2% -$7.94K 0.04% 64
2017
Q2
$491K Buy
8,030
+3,164
+65% +$193K 0.04% 57
2017
Q1
$295K Buy
4,866
+80
+2% +$4.85K 0.03% 78
2016
Q4
$269K Sell
4,786
-45
-0.9% -$2.63K 0.03% 81
2016
Q3
$288K Buy
4,831
+458
+10% +$26.8K 0.03% 82
2016
Q2
$240K Buy
4,373
+645
+17% +$34.3K 0.03% 84
2016
Q1
$188K Buy
3,728
+239
+7% +$11.7K 0.02% 103
2015
Q4
$176K Sell
3,489
-313
-8% -$15.8K 0.03% 100
2015
Q3
$179K Buy
3,802
+3
+0.1% +$159 0.06% 91
2015
Q2
$206K Buy
3,799
+965
+34% +$54.1K 0.07% 91
2015
Q1
$155K Buy
+2,834
New +$160K 0.06% 105
2014
Q4
Sell
-12,386
Closed -$700K 127
2014
Q3
$700K Buy
+12,386
New +$696K 0.27% 30

Other funds holding MRK

Allworth Financial's MRK Position: Q1 2026 in Review

Allworth Financial increased its Merck (MRK) stake by 24% in Q1 2026, buying an estimated $5.88M and bringing the position to 262,901 shares worth $31.6M. The position accounts for 0.13% of the portfolio, ranked #103.

Allworth Financial first reported a position in MRK in Q3 2014 and has held it in 46 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Allworth Financial held 262,901 shares of Merck worth $31.6M as of Q1 2026.
  • Allworth Financial bought 50,970 Merck shares in Q1 2026, an estimated $5.88M.
  • Merck made up 0.13% of Allworth Financial's portfolio in Q1 2026, its #103 holding.
  • Allworth Financial first reported a position in Merck in Q3 2014 and has held it in 46 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.